The role of intravesical prostatic protrusion (IPP) in the evaluation and treatment of bladder outlet obstruction (BOO)
Autor: | Jonathan Shunming Teo, Tricia Li Chuen Kuo, Keong Tatt Foo |
---|---|
Rok vydání: | 2015 |
Předmět: |
medicine.medical_specialty
Medical treatment business.industry Urology 030232 urology & nephrology Gold standard (test) medicine.disease Predictive value Surgery 03 medical and health sciences Bladder outlet obstruction 0302 clinical medicine medicine.anatomical_structure Prostate Lower urinary tract symptoms 030220 oncology & carcinogenesis Medicine Neurology (clinical) Trial without catheter business Clinical progression |
Zdroj: | Neurourology and Urodynamics. 35:535-537 |
ISSN: | 0733-2467 |
DOI: | 10.1002/nau.22741 |
Popis: | Aims Intravesical prostatic protrusion (IPP) may be an underutilized modality for the assessment of bladder outlet obstruction (BOO). Pressure flow studies or urodynamics have long been the gold standard for the evaluation of lower urinary tract symptoms (LUTS) in men but are invasive, time-consuming and costly. Potentially, IPP may be a useful adjunct prior to performing urodynamics. Methods Measurement of IPP is taken in the sagittal view, using the transabdominal ultrasound. It is the vertical height from the tip of the protrusion to the base of the prostate. This technique was previously described. We reviewed previous publications that studied the accuracy, positive predictive value and clinical use of IPP. In addition, we noted the comments regarding the challenges of using this technique. Results IPP has been shown to have a positive predictive value of 72% for BOO. It has been calculated to have an area under curve (AUC) value of 0.71 and 0.84 in some stuies. Clinically, it may be used to predict the outcome of a trial without catheter following acute retention of urine. Patients with higher IPP grade were noted to have a higher risk of clinical progression. Studies have also shown that men with higher IPP are poorer responders to medical treatment such as α-blockers. Conclusions Compared to other modalities, the advantage of IPP in assessing BOO may be its easy applicability and non-invasive nature. Therefore, there is a consideration for a larger role of IPP in bedside assessment and management of BOO in daily practice. Neurourol. Urodynam. 35:535–537, 2016. © 2015 Wiley Periodicals, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |